59 related articles for article (PubMed ID: 2499190)
1. Use of a proprietary database to examine lengths of hospital stay of patients who received drug therapy for acute myocardial infarction.
Hopkins LE; Crabbe SJ; Chase SL
Am J Hosp Pharm; 1989 May; 46(5):957-61. PubMed ID: 2499190
[TBL] [Abstract][Full Text] [Related]
2. Coronary care unit requirements of patients with acute myocardial infarction treated with or without thrombolytic therapy: a pilot study.
Sadaniantz BT; Sadaniantz A; Garber CE
Heart Lung; 1994; 23(4):328-32. PubMed ID: 7960859
[TBL] [Abstract][Full Text] [Related]
3. Clinical redesign using all patient refined diagnosis related groups.
Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
[TBL] [Abstract][Full Text] [Related]
4. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
[TBL] [Abstract][Full Text] [Related]
5. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
Chandra H; Yarzebski J; Goldberg RJ; Savageau J; Singleton C; Gurwitz JH; Gore JM
Arch Intern Med; 1997 Apr; 157(7):741-6. PubMed ID: 9125005
[TBL] [Abstract][Full Text] [Related]
6. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
[TBL] [Abstract][Full Text] [Related]
7. Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care?
Harrison ML; Graff LA; Roos NP; Brownell MD
CMAJ; 1995 Sep; 153(6):745-51. PubMed ID: 7664228
[TBL] [Abstract][Full Text] [Related]
8. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
[TBL] [Abstract][Full Text] [Related]
9. Health insurance coverage and outcome following acute myocardial infarction. A community-wide perspective.
Kreindel S; Rosetti R; Goldberg R; Savageau J; Yarzebski J; Gore J; Russo A; Bigelow C
Arch Intern Med; 1997 Apr; 157(7):758-62. PubMed ID: 9125007
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous streptokinase versus heparin in recent acute myocardial infarction. Randomized multicenter study in the Franche-Comté].
Bassand JP; Faivre R; Becqué O; Habert C; Schuffenecker M; Petiteau PY; Cardot JC; Verdenet J; Laroze M; Maurat JP
Arch Mal Coeur Vaiss; 1986 Apr; 79(4):421-8. PubMed ID: 3090959
[TBL] [Abstract][Full Text] [Related]
11. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
[TBL] [Abstract][Full Text] [Related]
12. Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction.
Stenestrand U; Lindbäck J; Wallentin L
Am Heart J; 2005 Jan; 149(1):82-90. PubMed ID: 15660038
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
[TBL] [Abstract][Full Text] [Related]
14. Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective.
Spencer FA; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Arch Intern Med; 2004 Apr; 164(7):733-40. PubMed ID: 15078642
[TBL] [Abstract][Full Text] [Related]
15. An audit of thrombolytic therapy in a rural hospital.
Cohen S; Gibb S
Aust Fam Physician; 1993 Oct; 22(10):1866-8. PubMed ID: 8280016
[TBL] [Abstract][Full Text] [Related]
16. [Fibrinolysis in acute myocardial infarct. Treatment rate, assessment and follow-up treatment in the Zürich hospitals].
Marx BE; Bertel O; Baumann PC; Koller M; Steinbrunn W; Dürst U; Speiser K
Schweiz Med Wochenschr; 1988 Nov; 118(47):1753-7. PubMed ID: 3144736
[TBL] [Abstract][Full Text] [Related]
17. [Evaluating the first German diagnosis-related groups (G-DRG) in cardiological patients: problems in the correct medical and economic grouping].
Reinecke H; Bunzemeier H; Fürstenberg T; Rothenburger M; Böcker D; Scheld HH; Breithardt G; Roeder N
Z Kardiol; 2003 Jul; 92(7):581-94. PubMed ID: 12883843
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.
Kiyota Y; Schneeweiss S; Glynn RJ; Cannuscio CC; Avorn J; Solomon DH
Am Heart J; 2004 Jul; 148(1):99-104. PubMed ID: 15215798
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
[TBL] [Abstract][Full Text] [Related]
20. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.
McLaughlin TJ; Soumerai SB; Willison DJ; Gurwitz JH; Borbas C; Guadagnoli E; McLaughlin B; Morris N; Cheng SC; Hauptman PJ; Antman E; Casey L; Asinger R; Gobel F
Arch Intern Med; 1996 Apr; 156(7):799-805. PubMed ID: 8615714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
